Literature DB >> 21396709

The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells.

Kyobum Kim1, David Dean, Jonathan Wallace, Rob Breithaupt, Antonios G Mikos, John P Fisher.   

Abstract

Scaffold design parameters, especially physical construction factors such as mechanical stiffness of substrate materials, pore size of 3D porous scaffolds, and channel geometry, are known to influence the osteogenic signal expression and subsequent differentiation of a transplanted cell population. In this study of photocrosslinked poly(propylene fumarate) (PPF) and diethyl fumarate (DEF) scaffolds, the effect of DEF incorporation ratio and pore size on the osteogenic signal expression of rat bone marrow stromal cells (BMSCs) was investigated. Results demonstrated that DEF concentrations and pore sizes that led to increased scaffold mechanical stiffness also upregulated osteogenic signal expression, including bone morphogenic protein-2 (BMP-2), fibroblast growth factors-2 (FGF-2), transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor (VEGF), and Runx2 transcriptional factor. Similar scaffold fabrication parameters supported rapid BMSC osteoblastic differentiation, as demonstrated by increased alkaline phosphatase (ALP) and osteocalcin expression. When scaffolds with random architecture, fabricated by porogen leaching, were compared to those with controlled architecture, fabricated by stereolithography (SLA), results showed that SLA scaffolds with the highly permeable and porous channels also have significantly higher expression of FGF-2, TGF-β1, and VEGF. Subsequent ALP expression and osteopontin secretion were also significantly increased in SLA scaffolds. Based upon these results, we conclude that scaffold properties provided by additive manufacturing techniques such as SLA fabrication, particularly increased mechanical stiffness and high permeability, may stimulate dramatic BMSC responses that promote rapid bone tissue regeneration.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396709      PMCID: PMC3075725          DOI: 10.1016/j.biomaterials.2011.01.016

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  55 in total

Review 1.  Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations.

Authors:  H Senta; H Park; E Bergeron; O Drevelle; D Fong; E Leblanc; F Cabana; S Roux; G Grenier; N Faucheux
Journal:  Cytokine Growth Factor Rev       Date:  2009-06-02       Impact factor: 7.638

2.  Pore architecture of a bovine acellular vocal fold scaffold.

Authors:  Chet C Xu; Roger W Chan
Journal:  Tissue Eng Part A       Date:  2008-11       Impact factor: 3.845

3.  Dense collagen matrix accelerates osteogenic differentiation and rescues the apoptotic response to MMP inhibition.

Authors:  P G Buxton; M Bitar; K Gellynck; M Parkar; R A Brown; A M Young; J C Knowles; S N Nazhat
Journal:  Bone       Date:  2008-04-15       Impact factor: 4.398

4.  The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering.

Authors:  Ciara M Murphy; Matthew G Haugh; Fergal J O'Brien
Journal:  Biomaterials       Date:  2009-10-09       Impact factor: 12.479

5.  Negative regulation by p70 S6 kinase of FGF-2-stimulated VEGF release through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.

Authors:  Shinji Takai; Haruhiko Tokuda; Yoshiteru Hanai; Atsushi Harada; Eisuke Yasuda; Rie Matsushima-Nishiwaki; Hisaaki Kato; Shinji Ogura; Toshiki Ohta; Osamu Kozawa
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

6.  The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model.

Authors:  Sara M Mantila Roosa; Jessica M Kemppainen; Erin N Moffitt; Paul H Krebsbach; Scott J Hollister
Journal:  J Biomed Mater Res A       Date:  2010-01       Impact factor: 4.396

7.  Porosity and pore size of beta-tricalcium phosphate scaffold can influence protein production and osteogenic differentiation of human mesenchymal stem cells: an in vitro and in vivo study.

Authors:  Philip Kasten; Ingo Beyen; Philipp Niemeyer; Reto Luginbühl; Marc Bohner; Wiltrud Richter
Journal:  Acta Biomater       Date:  2008-06-11       Impact factor: 8.947

8.  Differential effects of designed scaffold permeability on chondrogenesis by chondrocytes and bone marrow stromal cells.

Authors:  Jessica M Kemppainen; Scott J Hollister
Journal:  Biomaterials       Date:  2009-10-08       Impact factor: 12.479

9.  ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK.

Authors:  Chirag B Khatiwala; Peter D Kim; Shelly R Peyton; Andrew J Putnam
Journal:  J Bone Miner Res       Date:  2009-05       Impact factor: 6.741

10.  The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.

Authors:  Nadiya M Teplyuk; Larisa M Haupt; Ling Ling; Christian Dombrowski; Foong Kin Mun; Saminathan S Nathan; Jane B Lian; Janet L Stein; Gary S Stein; Simon M Cool; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

View more
  34 in total

1.  The role of scaffold architecture and composition on the bone formation by adipose-derived stem cells.

Authors:  Heidi A Declercq; Tim Desmet; Peter Dubruel; Maria J Cornelissen
Journal:  Tissue Eng Part A       Date:  2013-10-17       Impact factor: 3.845

2.  Biodegradable composite scaffolds incorporating an intramedullary rod and delivering bone morphogenetic protein-2 for stabilization and bone regeneration in segmental long bone defects.

Authors:  A M Henslee; P P Spicer; D M Yoon; M B Nair; V V Meretoja; K E Witherel; J A Jansen; A G Mikos; F K Kasper
Journal:  Acta Biomater       Date:  2011-06-30       Impact factor: 8.947

Review 3.  Stereolithography in tissue engineering.

Authors:  Shelby A Skoog; Peter L Goering; Roger J Narayan
Journal:  J Mater Sci Mater Med       Date:  2013-12-04       Impact factor: 3.896

4.  25-Hydroxyvitamin D(3)-loaded PLA microspheres: in vitro characterization and application in diabetic periodontitis models.

Authors:  Hao Li; Qi Wang; Yu Xiao; Chongyun Bao; Wei Li
Journal:  AAPS PharmSciTech       Date:  2013-05-08       Impact factor: 3.246

5.  Three-Dimensional Printing of Tissue Engineering Scaffolds with Horizontal Pore and Composition Gradients.

Authors:  Luis Diaz-Gomez; Panayiotis D Kontoyiannis; Anthony J Melchiorri; Antonios G Mikos
Journal:  Tissue Eng Part C Methods       Date:  2019-07       Impact factor: 3.056

Review 6.  The potential impact of bone tissue engineering in the clinic.

Authors:  Ruchi Mishra; Tyler Bishop; Ian L Valerio; John P Fisher; David Dean
Journal:  Regen Med       Date:  2016-08-23       Impact factor: 3.806

7.  Multimaterial Dual Gradient Three-Dimensional Printing for Osteogenic Differentiation and Spatial Segregation.

Authors:  Brandon T Smith; Sean M Bittner; Emma Watson; Mollie M Smoak; Luis Diaz-Gomez; Eric R Molina; Yu Seon Kim; Carrigan D Hudgins; Anthony J Melchiorri; David W Scott; K Jane Grande-Allen; James J Yoo; Anthony Atala; John P Fisher; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2019-12-27       Impact factor: 3.845

8.  MicroRNA profiles of BMSCs induced into osteoblasts with osteoinductive medium.

Authors:  Zhixiong Yan; Yong Guo; Yang Wang; Yanan Li; Jiahui Wang
Journal:  Exp Ther Med       Date:  2018-01-08       Impact factor: 2.447

Review 9.  Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems.

Authors:  Andrew B Yeatts; Daniel T Choquette; John P Fisher
Journal:  Biochim Biophys Acta       Date:  2012-06-15

10.  Cryotemplation for the Rapid Fabrication of Porous, Patternable Photopolymerized Hydrogels.

Authors:  Aline M Thomas; Lonnie D Shea
Journal:  J Mater Chem B       Date:  2014-07-28       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.